Market Cap 37.58M
Revenue (ttm) 1.45M
Net Income (ttm) -7.19M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -495.86%
Debt to Equity Ratio 0.00
Volume 200
Avg Vol 7,158
Day's Range N/A - N/A
Shares Out 4.84M
Stochastic %K 54%
Beta -0.06
Analysts Strong Sell
Price Target $23.50

Latest News on DXR

Daxor Corporation (DXR) Q4 2024 Earnings Call Transcript

Mar 6, 2025, 9:00 PM EST - 7 weeks ago

Daxor Corporation (DXR) Q4 2024 Earnings Call Transcript


Daxor to Exhibit at World's Largest Critical Care Conference

Feb 18, 2025, 8:00 AM EST - 2 months ago

Daxor to Exhibit at World's Largest Critical Care Conference


Daxor Corporation (DXR) Q4 2023 Earnings Call Transcript

Mar 25, 2024, 8:05 PM EDT - 1 year ago

Daxor Corporation (DXR) Q4 2023 Earnings Call Transcript